Literature DB >> 26002513

Differential expression and function of CD27 in chronic lymphocytic leukemia cells expressing ZAP-70.

Sandrine T Lafarge1, Sen Hou2, Samantha D Pauls3, James B Johnston4, Spencer B Gibson5, Aaron J Marshall6.   

Abstract

Chronic lymphocytic leukemia is a malignancy driven by abberant B cell signaling and survival. Leukemic B cells accumulate in the peripheral blood and the lymphoid organs where contact with stromal cells and T cells provide critical survival signals. Clinical severity of CLL is associated with several prognostic markers including expression of the kinase ZAP-70. ZAP-70 expression enhances signaling via the B cell antigen receptor and is associated with increased cell adhesion and migration capacity. Here we report that ZAP-70-positive CLL patients display significantly higher expression of the TNF superfamily receptor and memory marker CD27 than do ZAP-70 negative patients. CD27 expression by CLL was acutely elevated upon BCR cross-linking, or upon ectopic expression of ZAP-70. CD27 expression correlated with functional capacity to adhere to stromal cells and antibody blockade of CD27 impaired CLL binding to stroma. These results provide the first evidence for differential expression of CD27 among CLL prognostic groups, suggest a role for ZAP-70 dependent signaling in CD27 induction and implicate CD27 in cell-cell interactions with the lymphoid tissue microenvironment.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adhesion; CD27; Chronic lymphocytic leukemia; ZAP-70

Mesh:

Substances:

Year:  2015        PMID: 26002513     DOI: 10.1016/j.leukres.2015.04.016

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  2 in total

1.  SAMHD1 Limits the Efficacy of Forodesine in Leukemia by Protecting Cells against the Cytotoxicity of dGTP.

Authors:  Tamara Davenne; Jenny Klintman; Sushma Sharma; Rachel E Rigby; Henry T W Blest; Chiara Cursi; Anne Bridgeman; Bernadeta Dadonaite; Kim De Keersmaecker; Peter Hillmen; Andrei Chabes; Anna Schuh; Jan Rehwinkel
Journal:  Cell Rep       Date:  2020-05-12       Impact factor: 9.423

2.  Revealing a Phenotypical Appearance of Ibrutinib Resistance in Patients With Chronic Lymphocytic Leukaemia by Flow Cytometry.

Authors:  Ferenc Takács; Lili Kotmayer; Ágnes Czeti; Gábor Szalóki; Tamás László; Gábor Mikala; Ágnes Márk; András Masszi; Péter Farkas; Márk Plander; Júlia Weisinger; Judit Demeter; Sándor Fekete; László Szerafin; Beáta Margit Deák; Erika Szaleczky; Adrienn Sulák; Zita Borbényi; Gábor Barna
Journal:  Pathol Oncol Res       Date:  2022-09-21       Impact factor: 2.874

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.